Sunscreen Product Recalled Due to Manufacturing Quality Deviations
CLEARSTEM YOU ARE SUNSHINE SPF 50 sunscreen (4,890 bottles, Lot D54447) is being recalled due to manufacturing quality control deviations. The product was distributed in CA, CO, FL, PR, and WA.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall with no reported illnesses or injuries. The hazard is a procedural manufacturing deviation without specified consumer harm, making it a precautionary recall.
Plain-English summary
CLEARSTEM YOU ARE SUNSHINE SPF 50, a zinc oxide-based sunscreen product, is being recalled. The product is distributed by CLEARSTEM Skincare and comes in 2.1 oz (61g) bottles. Approximately 4,890 bottles with Lot D54447 (expiration date 11/30/2027) are affected.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. This is a voluntary recall initiated by the firm on October 10, 2025.
The product was distributed to CA, CO, FL, PR, and WA. Consumers who have purchased this product should contact CLEARSTEM Skincare via clearstemskincare.com for further instructions if they have questions or concerns.
The recalled product
- Product
- CLEARSTEM YOU ARE SUNSHINE SPF 50, Zinc Oxide 21%, 2.1 oz/61g per bottle, Distributed by: CLEARSTEM Skincare, clearstemskincare.com. NDC: 35192-046-17
- Manufacturer
- CA BOTANA International, Inc.
- Category
- Drug — Sunscreen
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot D54447
- exp 11/30/2027
Distribution
Distributed in 5 states:
- CA
- CO
- FL
- PR
- WA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27